Phase I Evaluation of Δ <i>virG Shigella sonnei</i> Live, Attenuated, Oral Vaccine Strain WRSS1 in Healthy Adults
Karen L. Kotloff(University of Maryland, Baltimore), Thomas L. Hale(Walter Reed Army Institute of Research), David Katz(Walter Reed Army Institute of Research), William D. Picking(Yale University), Myron M. Levine(University of Maryland, Baltimore), Malabi M. Venkatesan(Walter Reed Army Institute of Research), Antoinette B. Hartman(Walter Reed Army Institute of Research), Steven S. Wasserman(University of Maryland, Baltimore), Genevieve A. Losonsky(University of Maryland, Baltimore), David N. Taylor(Texas Chiropractic College), James D. Campbell(Centers for Disease Control and Prevention), James P. Nataro(University of Maryland, Baltimore), Marcelo B. Sztein(University of Maryland, Baltimore)
Cited by 113
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet Infectious Diseases|2017|1.4k
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
|PubMed|1999|1.3k
Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study
|The Lancet|2019|923
Origins of the <i>E. coli</i> Strain Causing an Outbreak of Hemolytic–Uremic Syndrome in Germany
|New England Journal of Medicine|2011|833